Rodney Sinclair

Treatment of alopecia areata of the beard with baricitinib.

Anthony Moussa, Samantha Eisman, Rodney Daniel Sinclair, Bevin Bhoyrul

Journal article  |  2023  |  J Am Acad Dermatol

Eyebrows and Eyelashes Regrowth Across Different SALT Response Thresholds in Patients with Alopecia Areata: Outcomes from the BRAVE AA Clinical Program

Maryanne Senna, Ohsang Kwon, Bianca Piraccini, Rodney Sinclair, Susan Ball, Yuxin Ding, Yun-Fei Chen, Yves Dutronc, Brett King

Journal article  |  2023  |  SKIN The Journal of Cutaneous Medicine

Trajectories For Scalp Hair Regrowth In Patients With Severe Alopecia Areata Treated With Baricitinib

Brett King, Jerry Shapiro, Manabu Ohyama, Alexander Egeberg, Yves Dutronc, Yun-Fei Chen, Wen-Shuo Wu, Yuxin Ding, Najwa Somani, Rodney Sinclair

Journal article  |  2023  |  SKIN The Journal of Cutaneous Medicine

Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.

Alexa B Kimball, Gregor BE Jemec, Afsaneh Alavi, Ziad Reguiai, Alice B Gottlieb, Falk G Bechara, Carle Paul, Evangelos J Giamarellos Bourboulis, Axel P Villani, Andreas Schwinn, Franziska Ruëff, Larisha Pillay Ramaya, Adam Reich, Ines Lobo, Rodney Sinclair, Thierry Passeron, Antonio Martorell, Pedro Mendes-Bastos, Georgios Kokolakis, Pierre-Andre Becherel, et al.

Journal article  |  2023  |  Lancet

BACKGROUND: Few therapeutic options are available for patients with moderate-to-severe hidradenitis suppurativa. We aimed to asses..

Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).

Ohsang Kwon, Maryanne M Senna, Rodney Sinclair, Taisuke Ito, Yves Dutronc, Chen-Yen Lin, Guanglei Yu, Chiara Chiasserini, Jill McCollam, Wen-Shuo Wu, Brett King

Journal article  |  2023  |  Am J Clin Dermatol

BACKGROUND: The oral Janus kinase (JAK) inhibitor baricitinib has demonstrated efficacy for severe alopecia areata (AA) over 36 we..

Cross-specialty identification of the JAK1 inhibitor trial agent filgotinib as a potential therapy for alopecia areata.

Nicole Fagan, Glen A Doherty, Nekma Meah, Rodney Sinclair, Dmitri Wall

Journal article  |  2023  |  Br J Dermatol

First report of alopecia areata responding to the selective JAK1 inhibitor filgotinib. This case is a patient with coinciding Croh..

The reliability and validity of a measure to assess the health-related quality of life of female alopecia areata patients.

Huw Rees, Dmitri Wall, Laita Bokhari, Leila Asfour, Rodney Sinclair

Journal article  |  2023  |  Clin Exp Dermatol

Alopecia areata (AA) impacts on health-related quality of life (HRQoL). The Women's Androgenetic Alopecia Quality of Life (WAA-QoL..

Athena: Specialty Certificate Examination Case - Wrinkling of the palms post water exposure.

Andrew Awad, Themis Getsos Colla, Rodney Sinclair

Journal article  |  2023  |  Clin Exp Dermatol

A 13-year-old female patient presented with a 1-year history of irritation, dryness and wrinkling of her palms after 5 min of imme..

Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials.

Brett King, Arash Mostaghimi, Yutaka Shimomura, Abraham Zlotogorski, Gwang-Seong Choi, Ulrike Blume-Peytavi, Thierry Passeron, Katrin Holzwarth, Yves Dutronc, Jill McCollam, Fan Emily Yang, Sarah Stanley, Wen-Shuo Wu, Rodney Sinclair

Journal article  |  2023  |  Br J Dermatol

BACKGROUND: Baricitinib, an oral, selective, reversible Janus kinase (JAK)1/JAK2 inhibitor, is an approved treatment for adults wi..

Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial.

Khaled Ezzedine, Elena Peeva, Yuji Yamaguchi, Lori Ann Cox, Anindita Banerjee, George Han, Iltefat Hamzavi, Anand K Ganesan, Mauro Picardo, Diamant Thaçi, John E Harris, Jung Min Bae, Katsuhiko Tsukamoto, Rodney Sinclair, Amit G Pandya, Abigail Sloan, Dahong Yu, Kavita Gandhi, Michael S Vincent, Brett King

Journal article  |  2023  |  J Am Acad Dermatol

BACKGROUND: Vitiligo is a chronic autoimmune disorder characterized by depigmented patches of the skin. OBJECTIVE: To evaluate the..